More recently, advances in sequencing technology and the discovery that a high proportion of CCM patients also carry activating mutations in PIK3CA [34,116] have revised the two-hit hypothesis into a three-hit hypothesis. The gene discussed is PIK3CA; the disease is cerebral cavernous malformation.